Search

Emeis SA

Открыт

13.02 -2.18

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

13.1

Макс.

13.43

Ключевые показатели

By Trading Economics

Доход

-155M

Продажи

2.9B

Рентабельность продаж

-5.412

Сотрудники

83,500

EBITDA

577M

Рекомендации

By TipRanks

Рекомендации

Продажа

Прогноз на 12 месяцев

-33.97% downside

Рыночная статистика

By TradingEconomics

Рыночная капитализация

2.3B

Предыдущая цена открытия

15.2

Предыдущая цена закрытия

13.02

Emeis SA График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

5 нояб. 2025 г., 23:51 UTC

Отчет

CoreCivic Cuts Fiscal Year Guidance Amid Efforts to Launch New Detention Facilities

5 нояб. 2025 г., 23:10 UTC

Отчет

DBS Third Quarter Net Dips 2.0%

5 нояб. 2025 г., 22:55 UTC

Отчет

Arm Holdings 2Q Profit Climbs on Record Demand

5 нояб. 2025 г., 22:23 UTC

Отчет

NAB's Annual Profit Falls 2.9% Amid Higher Costs, Credit Impairments -- Update

5 нояб. 2025 г., 23:52 UTC

Отчет

United Overseas Bank 3Q Net Interest Income S$2.265B Vs. $2.46B >U11.SG

5 нояб. 2025 г., 23:49 UTC

Отчет

United Overseas Bank 3Q Total Income S$3.40B Vs. S$3.83B >U11.SG

5 нояб. 2025 г., 23:49 UTC

Отчет

United Overseas Bank 3Q Net S$443M Vs. Net S$1.61B >U11.SG

5 нояб. 2025 г., 23:45 UTC

Обсуждения рынка

Nikkei May Rise on Weaker Yen, U.S. Tech Rebound -- Market Talk

5 нояб. 2025 г., 23:42 UTC

Обсуждения рынка

Gold Edges Lower Amid Reduced Odds of Fed Rate-Cut -- Market Talk

5 нояб. 2025 г., 23:12 UTC

Отчет

Nutrien 3Q Adj EPS 97c >NTR.T

5 нояб. 2025 г., 23:11 UTC

Отчет

Nutrien: Initiating Review of Strategic Alternatives for Phosphate Business >NTR.T

5 нояб. 2025 г., 23:10 UTC

Отчет

Nutrien 3Q Sales $6.01B >NTR.T

5 нояб. 2025 г., 23:10 UTC

Обсуждения рынка
Отчет

AppLovin Says Conversion Rate Is Biggest Growth Lever -- Market Talk

5 нояб. 2025 г., 23:10 UTC

Отчет

Nutrien 3Q EPS 96c >NTR.T

5 нояб. 2025 г., 23:04 UTC

Отчет

Qualcomm Stock Slides After Earnings Beat -- Barrons.com

5 нояб. 2025 г., 23:03 UTC

Обсуждения рынка

Macklem: Canada's Regulatory Overlap Turns Off Foreign Investors -- Market Talk

5 нояб. 2025 г., 22:55 UTC

Обсуждения рынка

Macklem Says Inflation and Productivity Are Intertwined -- Market Talk

5 нояб. 2025 г., 22:55 UTC

Отчет

AppLovin Reports Strong Earnings. The Stock Is Up. -- Barrons.com

5 нояб. 2025 г., 22:51 UTC

Отчет

DBS 3Q Total Income S$5.93B, Up 3% on Year >D05.SG

5 нояб. 2025 г., 22:50 UTC

Отчет

DBS 3Q Net S$2.95B, Down 2.0% on Year >D05.SG

5 нояб. 2025 г., 22:44 UTC

Приобретения, слияния, поглощения

Pfizer Preps Improved Offer in Metsera Bidding War -- Update

5 нояб. 2025 г., 22:43 UTC

Обсуждения рынка
Отчет

NAB's Flat Dividend Disappoints Bears at Jarden -- Market Talk

5 нояб. 2025 г., 22:36 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

5 нояб. 2025 г., 22:36 UTC

Обсуждения рынка

Macklem Warns Structural Adjustment Means Slow Canadian Growth -- Market Talk

5 нояб. 2025 г., 22:20 UTC

Обсуждения рынка

Bank of Canada Says Budget Plan Identifies Economy's Biggest Weakness -- Market Talk

5 нояб. 2025 г., 22:12 UTC

Приобретения, слияния, поглощения

Pfizer: Will Take Action to Preserve Rights Under Previously-Signed Agreement >PFE

5 нояб. 2025 г., 22:11 UTC

Приобретения, слияния, поглощения

Pfizer: Confident in Merits of Claims, Belief Metsera Has Acted in Breach of Contractual Obligations >PFE

5 нояб. 2025 г., 22:11 UTC

Приобретения, слияния, поглощения

Pfizer Responds to Delaware Chancery Court Ruling

5 нояб. 2025 г., 22:01 UTC

Отчет

Great-West Lifeco 3Q Net C$1.16B >GWO.T

5 нояб. 2025 г., 22:01 UTC

Отчет

Great-West Lifeco 3Q Adj EPS C$1.33 >GWO.T

Emeis SA Прогноз

Целевая цена

By TipRanks

-33.97% падение

Прогноз на 12 месяцев

Средняя 9 EUR  -33.97%

Максимум 9 EUR

Минимум 9 EUR

Основано на мнении 1 аналитиков Wall Street, спрогнозировавших целевые цены для Emeis SA на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Продажа

1 ratings

0

Покупка

0

Удержание

1

Продажа

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

EBITDA

Операционная прибыль

$

О компании Emeis SA

emeis Société anonyme operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. Its nursing home facilities provide personalized support services; and logistical and residential services, including accommodation, meals, and laundry and room cleaning, as well as various daily event, entertainment, and therapeutic workshop services. The company's post-acute and rehabilitation hospitals offer services for geriatrics, musculoskeletal, nervous system, cardiovascular, hematology, and oncology conditions, as well as patients in a persistent vegetative state or in a minimally conscious state. Its psychiatric hospitals provide services for the patients with mood disorders, anxiety disorders, obsessive-compulsive disorders, addictions, eating disorders, sleep disorders, personality disorders, ageing-related psychiatric disorders, psychosis, over exhaustion or burn-out, chronic fatigue syndrome, fibromyalgia, psychosomatic conditions, and post-traumatic stress disorder conditions, as well as geriatric, child, young adult, parent-child, and public/private patients psychiatry services. In addition, the company offers home care services, including housekeeping services, such as cleaning, meals, ironing, gardening, and household errands; daily life assistance services comprising day or night supervision, assistance with hygiene tasks, and meal-time assistance; and movement assistance services. It operates in France, Belgium, Spain, Italy, Ireland, Switzerland, Austria, Germany, the Czech Republic, Poland, the Netherlands, Luxembourg, Portugal, Brazil, Russia, Slovenia, Uruguay, Colombia, Mexico, Chile, Latvia, Croatia, and China. The company was founded in 1989 and is headquartered in Puteaux, France.
help-icon Live chat